MX2015014825A - Ensayos para la identificacion de compuestos que modulan el sabor amargo. - Google Patents

Ensayos para la identificacion de compuestos que modulan el sabor amargo.

Info

Publication number
MX2015014825A
MX2015014825A MX2015014825A MX2015014825A MX2015014825A MX 2015014825 A MX2015014825 A MX 2015014825A MX 2015014825 A MX2015014825 A MX 2015014825A MX 2015014825 A MX2015014825 A MX 2015014825A MX 2015014825 A MX2015014825 A MX 2015014825A
Authority
MX
Mexico
Prior art keywords
bitter taste
identifying compounds
agonists
present
provides methods
Prior art date
Application number
MX2015014825A
Other languages
English (en)
Inventor
Harish Radhakrishna
Maya Jenkins
Jonathan Anobile
Original Assignee
Chromocell Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chromocell Corp filed Critical Chromocell Corp
Publication of MX2015014825A publication Critical patent/MX2015014825A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Seasonings (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

La presente invención se basa en el descubrimiento de los solicitantes, divulgado en la presente, de los agonistas para los receptores TAS2R TAS2R1; TAS2R4, TAS2R9, TAS2R13, TAS2R14, TAS2R16, TAS2R38, TAS2R39, TAS2R44, TAS2R46 Y TAS2R60. La asignación de los agonistas para estos recetores hacen posible los ensayos para la identificación de compuestos que modulen el sabor amargo. Por ejemplo, la presente invención proporciona métodos para identificar compuestos que inhiban el sabor amargo debido a estos agonistas. La presente invención proporciona métodos para identificar compuestos que inhiban de manera selectiva el sabor amargo debido a estos agonistas. Además, la presente invención proporciona métodos para identificar compuestos que imiten el sabor amargo debido a estos agonistas. La presente invención también proporciona métodos para identificar compuestos que mejoren el sabor amargo debido a estos agonistas.
MX2015014825A 2013-04-24 2014-04-23 Ensayos para la identificacion de compuestos que modulan el sabor amargo. MX2015014825A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361815592P 2013-04-24 2013-04-24
PCT/US2014/035147 WO2014176336A1 (en) 2013-04-24 2014-04-23 Assays for identifying compounds that modulate bitter taste

Publications (1)

Publication Number Publication Date
MX2015014825A true MX2015014825A (es) 2016-05-31

Family

ID=51792362

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015014825A MX2015014825A (es) 2013-04-24 2014-04-23 Ensayos para la identificacion de compuestos que modulan el sabor amargo.

Country Status (11)

Country Link
US (1) US9927424B2 (es)
EP (1) EP2989464B1 (es)
JP (1) JP2016523512A (es)
CN (1) CN105358983B (es)
AU (1) AU2014257086A1 (es)
BR (1) BR112015026901A2 (es)
CA (1) CA2910161A1 (es)
MX (1) MX2015014825A (es)
RU (1) RU2015144371A (es)
SG (1) SG11201508572UA (es)
WO (1) WO2014176336A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017019890A1 (en) * 2015-07-28 2017-02-02 Mars, Incorporated Screening methods using canine t2r receptors and pet food products and compositions identified using the same
CN110553983B (zh) * 2019-09-05 2022-03-04 东北农业大学 一种牛奶中山梨酸钾的快速检测方法
JP2022546204A (ja) * 2019-09-09 2022-11-04 フィルメニッヒ インコーポレイテッド 苦味受容体ブロッカー及びその同定方法
EP4142507A1 (en) 2020-04-29 2023-03-08 Bunge Loders Croklaan B.V. Composition, confectionery product and process
CN112521449B (zh) * 2020-11-18 2022-04-22 渤海大学 两种具有苦味抑制作用的活性肽
WO2023205647A1 (en) * 2022-04-19 2023-10-26 Firmenich Incorporated Reduction of bitter taste of active pharmaceutical ingredients and related assays and screening methods

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118460A (en) 1996-05-28 1999-09-22 Dead Sea Works Ltd Edible salt mixture
WO2000038536A2 (en) 1998-12-23 2000-07-06 Mount Sinai School Of Medicine Of New York University Inhibitors of the bitter taste response
US6692965B1 (en) 1999-11-23 2004-02-17 Chromocell Corporation Isolation of living cells and preparation of cell lines based on detection and quantification of preselected cellular ribonucleic acid sequences
CN101397563A (zh) * 2000-04-07 2009-04-01 塞诺米克斯公司 T2r味觉受体及其编码基因
US8030008B2 (en) * 2001-04-05 2011-10-04 Senomyx, Inc. Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators
US7883856B2 (en) 2001-04-05 2011-02-08 Senomyx Inc. Identification of bitter ligands that specifically activate human T2R receptors and related assays for identifying human bitter taste modulators
AU2002318229B2 (en) * 2001-07-10 2008-03-13 Senomyx, Inc. Use of specific T2R taste receptors to identify compounds that block bitter taste
US20030039968A1 (en) 2001-07-10 2003-02-27 Applera Corporation Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
EP1543122B1 (en) 2002-09-25 2009-11-18 Deutsches Institut für Ernährungsforschung Bitter taste receptors
KR20100063144A (ko) 2004-02-18 2010-06-10 크로모셀 코포레이션 신호 프로브를 이용하는 방법 및 물질
US7829299B2 (en) 2004-11-18 2010-11-09 Deutsches Institut fur Ernahrungforschung Potsdam-Rehbrucke Stiftung des Offentlichen Rechts Agonists of bitter taste receptors and uses thereof
US7939276B2 (en) 2005-06-22 2011-05-10 Senomyx, Inc. Assays which screen for compounds that modulate bitter taste of chlorogenic lactone compounds
US7923047B2 (en) 2006-06-30 2011-04-12 Conagra Foods Rdm, Inc. Seasoning and method for seasoning a food product while reducing dietary sodium intake
US20080167286A1 (en) 2006-12-12 2008-07-10 Abbott Laboratories Pharmaceutical compositions and their methods of use
WO2008119197A1 (en) 2007-03-30 2008-10-09 Givaudan Sa 4-(2, 2, 3-trimethylcyclopentyl) butanoic acid used as an off-note masking agent in consumables
ATE555670T1 (de) 2007-03-30 2012-05-15 Givaudan Sa Off-note-blockierende sensorische organische verbindungen
KR20100016044A (ko) 2007-03-30 2010-02-12 지보당 에스아 조절제의 동정 방법
EP1983342A1 (en) 2007-04-18 2008-10-22 Deutsches Institut für Ernährungsforschung Potsdam -Rehbrücke-Stiftung des öffentlichen Rechts- Vertreten durch den Stiftungsvorstand Antogonists of bitter taste receptors and uses thereof
CN101355441B (zh) 2007-07-27 2012-04-04 华为技术有限公司 一种配置操作管理维护属性的方法、系统及设备
US8076491B2 (en) 2007-08-21 2011-12-13 Senomyx, Inc. Compounds that inhibit (block) bitter taste in composition and use thereof
CN103525751B (zh) 2008-02-01 2017-04-12 克罗莫塞尔公司 细胞系以及制备和使用其的方法
EP2300830B1 (en) 2008-06-13 2015-05-20 Givaudan SA Methods of identifying modulators of the bitter taste receptor tas2r44
EP2329263A1 (en) 2008-08-07 2011-06-08 Givaudan SA Methods to identify modulators of the interaction between dextromethorphan and the bitter taste receptor tas2r46
JP6297769B2 (ja) 2009-02-02 2018-03-20 クロモセル コーポレーション 新規の細胞株および方法
WO2010099983A1 (en) 2009-03-06 2010-09-10 Deutsches Institut Für Ernährungsforschung Potsdam-Rehbrücke Methods for isolating agonists and antagonists of taste receptors
US8673578B2 (en) 2009-10-27 2014-03-18 Deutsches Institut für Ernahrungsforschung Potsdam-Rehbrücke Methods of identifying antagonists of the hTAS2R46 bitter taste receptor
US20130040317A1 (en) 2011-08-08 2013-02-14 The University Of North Carolina At Chapel Hill Cell lines comprising endogenous taste receptors and their uses
IN2014MN00714A (es) * 2011-10-20 2015-07-03 Chromocell Corp

Also Published As

Publication number Publication date
AU2014257086A1 (en) 2015-11-12
CN105358983A (zh) 2016-02-24
US20160069860A1 (en) 2016-03-10
JP2016523512A (ja) 2016-08-12
CN105358983B (zh) 2018-08-03
SG11201508572UA (en) 2015-11-27
CA2910161A1 (en) 2014-10-30
US9927424B2 (en) 2018-03-27
BR112015026901A2 (pt) 2017-11-14
RU2015144371A (ru) 2017-05-29
WO2014176336A1 (en) 2014-10-30
EP2989464A1 (en) 2016-03-02
EP2989464A4 (en) 2016-12-07
EP2989464B1 (en) 2018-12-26

Similar Documents

Publication Publication Date Title
MX2018015592A (es) Anticuerpos inhibidores de puntos de control biespecificos.
PH12018500711A1 (en) Anti-pd1 antibodies and methods of use
MX2020009461A (es) Anticuerpos anti-proteína que contiene dominio de inmunologlubina rfig elacionado con el receptor de poliovirus (pvrig) y métodos de uso.
DOP2018000181A (es) Terapias de combinación para enfermedades malignas hematológicas con anticuerpos anti-cd38 e inhibidores de survivina
MX2017003478A (es) Anticuerpos anti-fgfr2/3 y metodos para su uso.
MX2015014825A (es) Ensayos para la identificacion de compuestos que modulan el sabor amargo.
MA40576B1 (fr) Anticorps et immunoconjugués anti-her2
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
EP4335874A3 (en) Anti-hla-g antibodies and use thereof
MX2015012334A (es) Metodos y composiciones para el control de malezas.
EP3702372A3 (en) Anti-cd40 human antibodies
EA201592213A1 (ru) Антитела антирецептор трансферрина и способы их использования
MX2016003843A (es) Inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos.
PH12016500482A1 (en) Combination therapy with an anti-ang2 antibody and a cd40 agonist
EA201591750A1 (ru) Антитела против b7-h4 и иммуноконъюгаты
EA201591285A1 (ru) Иммунотерапия тау
EA201691610A8 (ru) Анти-jagged1 антитела и способы применения
NZ761537A (en) Anti-human ox40l antibodies, uses & methods
PH12015501059A1 (en) Anti-hemagglutinin antibodies and methods of use
EA201591615A1 (ru) Замещенные ксантины и способы их применения
MX2020010951A (es) Anticuerpos anti-hla-g y utilizacion de los mismos.
PH12015501071A1 (en) Combination therapy of anti-her3 antibodies
MX2023006416A (es) Anticuerpos, usos y metodos.
PH12016500683B1 (en) Synthetic route to 2`-deoxy-2`,2`-difluorotetrahydrouridines
EA201491894A1 (ru) Способы лечения непереносимости лактозы